The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)

Psychoneuroendocrinology

Volumn 28, Issue SUPPL. 3, 2003, Pages 1-23

  Halbreich, Uriel ^a   Borenstein, Jeff ^b   Pearlstein, Terry ^c   Kahn, Linda S ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Depressions; Disease burden; Epidemiology; Premenstrual dysphoric disorder (PMDD); Premenstrual syndromes (PMS); Women

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM; DIURETIC AGENT; ESTROGEN; FLUOXETINE; HORMONE; MINERAL; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PRIMROSE OIL; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; VITAMIN;

AGORAPHOBIA; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DYSTHYMIA; EXERCISE; FLUID INTAKE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MENTAL DEFICIENCY; MENTAL INSTABILITY; MINERAL INTAKE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPATHY; QUALITY OF LIFE; SCHIZOPHRENIFORM DISORDER; SOCIAL ADAPTATION; SOCIAL PHOBIA; SOMATIZATION; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADULT; COST OF ILLNESS; FEMALE; MIDDLE AGED; PREMENSTRUAL SYNDROME; PSYCHOLOGICAL ASPECT; REVIEW;

ADOLESCENT; ADULT; COST OF ILLNESS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; PREMENSTRUAL SYNDROME; QUALITY OF LIFE;

EID: 0242482637     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00098-2     Document Type: Article

References (99)

1. American College of Obstetricians and Gynecologists (ACOG) 2000. Premenstrual Syndrome, vol. 15. ACOG, Washington, D.C.
2. American Psychiatric Association 1987. Diagnostic and Statistical Manual of Mental Disorders, Revised. 3rd edn. American Psychiatric Press Inc., Washington D.C.
3. American Psychiatric Association 1987. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Press Inc., Washington D.C.
4. Andersch, B., Wenderstam, C., Hahn, L., et al. 1986. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet & Gynaecol 5, 39.
5. Angst, J., Sellaro, R., Merikangas, K.R., Endicott, J., 2001. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatrica Scandinavica 104, 110-116.
6. Banerjee, N., Roy, K.K., Takkar, D., 2000. Premenstrual dysphoric disorder - a study from India. International Journal of Fertility & Womens Medicine 45, 342-344.
7. Brown, V.D., Freeman, E., Ling, F.W., 1998. An update on the treatment of premenstrual syndrome. Am J Managed Care 4, 266.
8. Bula, C.J., Wietlisbach, V., Burnand, B., Yersin, B., 2001. Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients. Arch Intern Med 161, 2609-2615.
9. Burton, W.N., Conti, D.J., Chen, C.Y., Schultz, A.B., Edington, D.W., 2001. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med. 43, 64-71.
10. Busch, C.M., Costa, P.T. Jr., Whitehead, W.E., Heller, B.R., 1988. Severe perimenstrual symptoms: prevalence and effects on absenteeism and health care seeking in a non-clinical sample. Women & Health 14, 59-74.
11. Campbell, E.M., Peterkin, D., O'Grady, K., Sanson-Fisher, R., 1997. Premenstrual symptoms in general practice patients. Prevalence and treatment. Journal of Reproductive Medicine 42, 637-646.
12. Chang, A.M., Holroyd, E., Chau, J.P., 1995. Premenstrual syndrome in employed Chinese women in Hong Kong. Health Care for Women International 16, 551-561.
13. Chau, J.P., Chang, A.M., 1998. Relationship between premenstrual tension syndrome and anxiety in Chinese adolescents. Journal of Adolescent Health 22, 247-249.
14. Chau, J.P., Chang, A.M., 1999. Effects of an educational programme on adolescents with premenstrual syndrome. Health Education Research 14, 817-830.
15. Chawla, A., Swindle, R., Long, S., Kennedy, S., Sternfeld, B., 2002. Premenstrual dysphoric disorder: is there an economic burden of illness? Medical Care 40, 1101-1112.
16. Cleckner-Smith, C.S., Doughty, A.S., Grossman, J.A., 1998. Premenstrual symptoms. Prevalence and severity in an adolescent sample. Journal of Adolescent Health 22, 403-408.
17. Cohen, L.S., Soares, C.N., Otto, M.W., Sweeney, B.H., Liberman, R.F., Harlow, B.L., 2002. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. Journal of Affective Disorders 70, 125-132.
18. de la Gandara Martin, J.J., de Diego Herrero, E., 1996. Premenstrual dysphoric disorder: an epidemiological study. Actas Luso-Espanolas de Neurologia. Psiquiatria y Ciencias Afines 24, 111-117.
19. Deuster, P.A., Adera, T., South-Paul, J., 1999. Biological, social, and behavioral factors associated with premenstrual syndrome. Archives of Family Medicine 8, 122-128.
20. DiMatteo, M.R., Lepper, H.S., Croghan, T.W., 2000. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160, 2101-2107.
21. Donker, G.A., Foets, M., Spreeuwenberg, P., 1999. Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract 49, 787-792.
22. Dott, S.G., Walling, D.P., Bishop, S.L., Bucy, J.E., Folkes, C.C., 1996. The efficacy of short-term treatment for improving quality of life: a pilot study. J Nerv Ment Dis. 184, 507-509.
23. Ekholm, V.B., Backstrom, T., 1994. Influence of premenstrual syndrome on family, social life, and work performance. Int J Health Serv 24, 629-649.
24. Endicott, J., Nee, J., Cohen, J., Halbreich, U., 1986. Premenstrual changes: Patterns and correlates of daily ratings. J Affect Disord. 10, 127-135.
25. Endicott, J., Nee, J., Harrison, W., Blumenthal, R., 1993. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharm Bull 29, 321-326.
26. Endicott, J., Harrison, W., 1990. Daily rating of severity of problems form. Department of Research and Training, New York State Psychiatric Institute, New York.
27. Ferrari, M.D., 1998. The economic burden of migraine to society. Pharmacoeconomics 13, 667-676.
28. Frank, B., Dixon, D.N., Grosz, H.J., 1993. Conjoint monitoring of symptoms of premenstrual syndrome: Impact on marital satisfaction. Journal of Counseling Psychology 40, 109-114.
29. Freeman, E.W., Rickels, K., Sondheimer, S.J., 1993. Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. Journal of Psychosomatic Obstetrics & Gynecology 14, 41-50.
30. Freeman, E.W., 2003. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2853, 23-35.
31. Gehlert, S., Hartlage, S., 1997. A design for studying the DSM-IV research criteria of premenstrual dysphoric disorder. Journal of Psychosomatic Obstetrics & Gynecology 18, 36-44.
32. Gerth, W.C., Carides, G.W., Dasbach, E.J., Visser, W.H., Santanello, N.C., 2001. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 19, 197-206.
33. Goldman, L.S., Nielsen, N.H., Champion, H.C., 1999. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 14, 569-580.
34. Greenberg, P.E., Birnbaum, H.G., Kessler, R.C., Morgan, M., Stang, P., 2001. Impact of illness and its treatment on workplace costs: regulatory and measurement issues. J Occup Environ Med. 43, 56-63.
35. Greenberg, P.E., Sisitsky, T., Kessler, R.C., Finkelstein, S.N., Berndt, E.R., Davidson, J.R., Ballenger, J.C., Fyer, A.J., 1999. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 60, 427-435.
36. Halbreich, U., 1995. Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 9, 163-175.
37. Halbreich, U., 1996. Premenstrual syndromes. In: Halbreich, U. (Ed.), Balliere's Clinical Psychiatry: International Practice and Research, vol. 2. Balliere Tindall, London, pp. 667-686.
38. Halbreich, U., 1999. Premenstrual syndromes: closing the 20th century chapters. Curr Opin Obstet Gynecol 11, 265-270.
39. Halbreich, U., Endicott, J., Schacht, S., Nee, J., 1982. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand 65, 46-65.
40. Hamilton, M., 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23, 56-62.
41. Hellman, J., Georgiev, N., 1987. The premenstrual syndrome and absence from work due to illness. J Psychosom Obstet Gynaecol. 6, 111-119.
42. Hurt, S.W., Schnurr, P.P., Severino, S.K., Freeman, E.W., Gise, L.H., Rivera-Tovar, A., Steege, J.F., 1992. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149, 525-530.
43. Hylan, T.R., Sundell, K., Judge, R., 1999. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom and France. Journal of Womens Health & Gender-Based Medicine 8, 1043-1052.
44. SAS Institute 1996. Statistical Analysis Software. SAS Institute Inc., North Carolina.
45. Janiger, O., Riffenburgh, R., Kersh, R., 1972. Cross cultural study of premenstrual symptoms. Psychosomatics 13, 226-235.
46. Johnson, S.R., 1987. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 30, 367-376.
47. Johnson, S.R., McChesney, C., Bean, J.A., 1988. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med. 33, 340-346.
48. Joish, V.N., Cady, P.S., Shaw, J.W., 2000. Health care utilization by migraine patients: a 1998 Medicaid population study. Clin Ther 22, 1346-1356.
49. Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Henk, H.J., 1997. Effect of primary care treatment of depression on service use by patients with high medical expenditures. Psychiatr Serv 48, 59-64.
50. Kay, G.G., Quig, M.E., 2001. Impact of sedating antihistamines on safety and productivity. Allergy Asthma Proc 22, 281-283.
51. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., Kendler, K.S., 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51, 8-19.
52. Kessler, R.C., Nelson, C.B., McGonagle, K.A., Liu, J., Swartz, M., Blazer, D.G., 1996. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl., 17-30.
53. Kimerling, R., Ouimette, P.C., Cronkite, R.C., Moos, R.H., 1999. Depression and outpatient medical utilization: a naturalistic 10-year follow-up. Ann Behav Med 21, 317-321.
54. Kocsis, J.H., Zisook, S., Davidson, J., Shelton, R., Yonkers, K., Hellerstein, D.J., Rosenbaum, J., Halbreich, U., 1997. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 154, 390-395.
55. Kraemer, G.R., Kraemer, R.R., 1998. Premenstrual syndrome: diagnosis and treatment experiences. Journal of Womens Health 7, 893-907.
56. Kuczmierczyk, A.R., Labrum, A.H., Johnson, C.C., 1992. Perception of family and work environments in women with premenstrual syndrome. J Psychosom Res. 36, 787-795.
57. Li-McLeod, J., Perfetto, E.M., 2001. Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin. Manag Care Interface 14, 52-59.
58. Lipton, R.B., Stewart, W.F., von Korff, M., 1997. Burden of migraine: societal costs and therapeutic opportunities. Neurology 48, S4-9.
59. Lofland, J.H., Johnson, N.E., Batenhorst, A.S., Nash, D.B., 1999. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Arch Intern Med 159, 857-863.
60. Merikangas, K.R., Foeldenyl, M., Angst, J., 1993. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243, 23-32.
61. Miller, I.W., Keitner, G.I., Schatzberg, A.F., Klein, D.N., Thase, M.E., Rush, A.J., 1998. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry 59, 608-619.
62. Most, A.F., Woods, N.F., Dery, G.K., Most, B.M., 1981. Distress associated with menstruation among Israeli women. International Journal of Nursing Studies 18, 61-71.
63. Murray, C.J.L., Lopez, A.D., 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, Global burden of disease and injury series. The Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Boston.
64. Muse, K., Cetel, N., Futterman, L., Yen, S.C., 1984. The premenstrual syndrome: effects of 'medical ovariectomy'. N Eng J Med. 311, 1345-1349.
65. Narrow, W.E., Rae, D.S., Robins, L.N., Regier, D.A., 2002. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 59, 115-123.
66. Panzarino, P.J. Jr., Nash, D.B., 2001. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Am J Manag Care 7, 173-184.
67. Pearlstein, T.B., Halbreich, U., Batzar, E.D., Brown, C.S., Endicott, J., Frank, E., Freeman, E.W., Harrison, W.M., Haskett, R.F., Stout, A.L., et al. 2000. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry. 61, 101-109.
68. Ramcharan, S., Love, E.J., Fick, G.H., Goldfien, A., 1992. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol. 45, 377-392.
69. Regier, D.A., Myers, J.K., Kramer, M., Robins, L.N., Blazer, D.G., Hough, R.L., Eaton, W.W., Locke, B.Z., 1984. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 41, 934-941.
70. Rivera-Tovar, A.D., Frank, E., 1990. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147, 1634-1636.
71. Robinson, R.L., Swindle, R.W., 2000. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. Journal of Womens Health & Gender-Based Medicine 9, 757-768.
72. Ryser, R., Feinauer, L.L., 1992. Premenstrual syndrome and the marital relationship. American Journal of Family Therapy 20, 179-190.
73. Scott-Levine Inc. Database, 2001.
74. Shye, D., Jaffe, B., 1991. Prevalence and correlates of perimenstrual symptoms: a study of Israeli teenage girls. Journal of Adolescent Health 12, 217-224.
75. Simon, G.E., Barber, C., Birnbaum, H.G., Frank, R.G., Greenberg, P.E., Rose, R.M., Wang, P.S., Kessler, R.C., 2001a. Depression and work productivity: the comparative costs of treatment versus nontreatment. J Occup Environ Med. 43, 2-9.
76. Simon, G.E., Manning, W.G., Katzelnick, D.J., Pearson, S.D., Henk, H.J., Helstad, C.S., 2001b. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Archives of General Psychiatry 58, 181-187.
77. Singh, B.B., Berman, B.M., Simpson, R.L., Annechild, A., 1998. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Alternative Therapies in Health & Medicine 4, 75-79.
78. Spitzer, R.L., Williams, J.B., Kroenke, K., Hornyak, R., McMurray, J., 2000. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 183, 759-769.
79. Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., Streiner, D., 1995. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Eng J Med. 332, 1529-1534.
80. Sveindottir, H., Backstrom, T., 2000. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 79, 405-413.
81. Thompson, D., Richardson, E., 1999. Current issues in the economics of depression management. Curr Psychiatry Rep 1, 125-134.
82. van den Akker, O.B., Eves, F.F., Service, S., Lennon, B., 1995. Menstrual cycle symptom reporting in three British ethnic groups. Social Science & Medicine 40, 1417-1423.
83. Wakefield, J.C., Spitzer, R.L., 2002. Lowered estimates-but of what? Arch Gen Psychiatry 59, 129-130.
84. Walen, H.R., Cronan, P.A., Bigatti, S.M., 2001. Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 7 Spec No, SP39-SP47.
85. Webster, J., Pritchard, M.A., Linnane, J.W., Roberts, J.A., Hinson, J.K., Starrenburg, S.E., 2001. Postnatal depression: use of health services and satisfaction with health-care providers. J Qual Clin Pract. 21, 144-148.
86. Weissman, M.M., Bothwell, S., 1976. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33, 1111-1115.
87. Weissman, M.M., Prusoff, B.A., Thompson, W.D., Harding, P.S., Myers, J.K., 1978. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 166, 317-326.
88. White, K.P., Speechley, M., Harth, M., Ostbye, T., 1999. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol 26, 885-889.
89. Williams, D., 1971. The menopause. British Medical Journal 2, 208-210.
90. Williams, J.B., Gibbon, M., First, M.B., Spitzer, R.L., Davies, M., Borus, J., Howes, M.J., Kane, J., Pope, H.G. Jr., Rounsaville, B., et al. 1992. The Structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 49, 630-636.
91. Winter, E.J., Ashton, D.J., Moore, D.L., 1991. Dispelling myths: a study of PMS and relationship satisfaction. Nurse Practitioner 16, 34.
92. Wittchen, H.U., Becker, E., Lieb, R., Krause, P., 2002. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine January 32, 119-132.
93. Wittchen, H.U., Hoyer, J., 2001. Generalized anxiety disorder: nature and course. Journal of Clinical Psychiatry 62 (15-19), 20-21 (discussion).
94. Wolfe, F., Anderson, J., Harkness, D., Bennett, R.M., Caro, X.J., Goldenberg, D.L., Russell, I.J., Yunus, M.B., 1997. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40, 1560-1570.
95. Woods, N.F., Most, A., Dery, G.K., 1982. Prevalence of perimenstrual symptoms. Am J Public Health 72, 1257-1264.
96. World Health Organization 2001. Mental Health: New Understanding, New Hope. WHO, Geneva.
97. Yonkers, K.A., Halbreich, U., Freeman, E., Brown, C., Pearlstein, T., 1996. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32, 41-46.
98. Yonkers, K.A., Halbriech, U., Freeman, E., Brown, C., Endicott, J., Frank, E., Parry, B., Pearlstein, T., Severino, S., Stout, A., et al. 1997. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 278, 983-988.
99. Yu, M., Zhu, X., Li, J., Oakley, D., Reame, N.E., 1996. Perimenstrual symptoms among Chinese women in an urban area of China. Health Care for Women International 17, 161-172.